<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000349.v1.p1" parentStudy="phs000349.v1.p1" createDate="2011-03-14" modDate="2011-05-02">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>David Herrington, MD, MHS</td><td>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</td></tr>
		<tr><td>Wake Forest Investigators</td><td>Carl Langefeld, PhD</td><td>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</td></tr>
		<tr><td>Wake Forest Investigators</td><td>Timothy Howard, PhD</td><td>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</td></tr>
		<tr><td>Wake Forest Investigators</td><td>Yongmei Liu, PhD</td><td>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</td></tr>
		<tr><td>LSU Investigators</td><td>Jack Strong, MD</td><td>Louisiana State University, New Orleans, LA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>SNPs and Extent of Atherosclerosis (SEA) Study</StudyNameEntrez>
	<StudyNameReportPage>SNPs and Extent of Atherosclerosis (SEA) Study</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cross-Sectional</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The SEA study is a genome-wide association study to identify genetic variants associated with premature atherosclerosis in 	subjects included in the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) repository - a unique NHLBI resource 	including data, DNA and arterial specimens from over 3000 multi-ethnic subjects 15-34 years of age who died of non-atherosclerotic 	causes (mostly trauma).  All PDAY subjects had post-mortem quantitative assessment of raised atherosclerotic lesions in their aorta 	and coronary arteries - making this the largest and most carefully phenotyped cohort for premature atherosclerosis in the world. 	The goal of the current project was to use the quantitative measure of raised atherosclerotic lesions in the PDAY cohort as the 	target phenotype for a genome-wide association study and to use quantitative measures of subclinical atherosclerosis (coronary 	calcium and carotid IMT) in the Multi-Ethnic Study of Atherosclerosis (MESA) to confirm or refute candidate loci identified from 	the PDAY analysis.  Identifying genetic factors that predispose individuals to premature atherosclerosis could lead to more 	effective screening and early treatment of high risk individuals and suggest novel molecular targets for treatment and prevention 	interventions.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><u>PDAY Population and Atherosclerosis Phenotype</u>: From 1987 to 1994 PDAY centers collected standardized autopsy specimens 	and selected risk factor data from black and white males and females, age 15-34 yrs, who died within 72 hours after injury. Using 	an unlinked anonymous coding system, the specimens and data were submitted to central pathology laboratories for detailed 	histopathologic analyses. The right coronary artery and left half of the aorta were stained with Sudan IV and the percent of 	intimal surface involved with raised atherosclerotic lesions in the distal and thoracic aorta and right coronary artery was 	independently estimated by three pathologists.  This produced a pathologically specific and quantitatively precise description 	of atherosclerosis extent that was strongly correlated with blood lipids and other conventional risk factors in the PDAY cohort*. 	For the current project the percent surface involvement in the distal and thoracic aorta and right coronary artery was summed 	and then adjusted for age^2, race and gender to produce a total raised lesion score which was the primary phenotype for 	our genetic association analyses.</p> 	<p>Cases were defined as the PDAY subjects at &gt;90th% for total raised lesion score. </p> 	<p>Controls were selected from among PDAY subjects with a total raised lesion score = 0 after matching to cases (2:1) on age, 	race and gender.</p> 	<p>In Phase I of the SEA Study quantitative genotyping was used to estimate allele frequency for &gt;2.4 million SNPs in each 	of eight pools of DNA (3 case and 5 control pools).  Pools were balanced for age, gender and genetic ancestry based on analysis 	of 311 ancestry informative markers typed on every sample before pool formation.  Phase II and III of the SEA study 	involved individual level genotyping of promising SNPs in the PDAY subjects and subsequent replication in the MESA cohort. 	Phase II and III data are not included in the dbGap data set.</p>     <p>*A more detailed description of the measurement of raised lesions in the PDAY cohort can be found in: Strong JP, Malcom GT, 	McMahan CA et al. Prevalence and extent of atherosclerosis in adolescents and young adults. Implications for prevention from 	the Pathobiological Determinants of Atherosclerosis in Youth study. JAMA 1999;281:727-35; PMID: 	<a href="http://www.ncbi.nlm.nih.gov/pubmed/10052443" target="_blank">10052443</a>.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="10052443"/>
		</Publication>
		<Publication>
			<Pubmed pmid="7813067"/>
		</Publication>
		<Publication>
			<Pubmed pmid="7749853"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9239187"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9012643"/>
		</Publication>
		<Publication>
			<Pubmed pmid="9672071"/>
		</Publication>
		<Publication>
			<Pubmed pmid="1680392"/>
		</Publication>
		<Publication>
			<Pubmed pmid="1525116"/>
		</Publication>
		<Publication>
			<Journal authors="Hixson JE, McMahan CA, Malcom GT, Strong JP, for the PDAY Research Group" title="Polymorphism in the apolipoprotein (a) gene promoter region and atherosclerosis in right coronary artery of young white males" journal="Pennington Ctr Nutr Series 1996;6:224-38"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Atherosclerosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>David Herrington, MD, MHS</AttName>
			<Institution>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</Institution>
		</Header>
		<Header title="Wake Forest Investigators">
			<AttName>Carl Langefeld, PhD</AttName>
			<Institution>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</Institution>
		</Header>
		<Header title="Wake Forest Investigators">
			<AttName>Timothy Howard, PhD</AttName>
			<Institution>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</Institution>
		</Header>
		<Header title="Wake Forest Investigators">
			<AttName>Yongmei Liu, PhD</AttName>
			<Institution>Wake Forest University Baptist Medical Center, Winston Salem, NC, USA</Institution>
		</Header>
		<Header title="LSU Investigators">
			<AttName>Jack Strong, MD</AttName>
			<Institution>Louisiana State University, New Orleans, LA, USA</Institution>
		</Header>
		<Header title="LSU Investigators">
			<AttName>Gray Malcom, PhD</AttName>
			<Institution>Louisiana State University, New Orleans, LA, USA</Institution>
		</Header>
		<Header title="LSU Investigators">
			<AttName>Robin Goey, MD</AttName>
			<Institution>Louisiana State University, New Orleans, LA, USA</Institution>
		</Header>
		<Header title="LSU Investigators">
			<AttName>Dana Troxclair, MD</AttName>
			<Institution>Louisiana State University, New Orleans, LA, USA</Institution>
		</Header>
		<Header title="UT-Houston Investigators">
			<AttName>James Hixson, PhD</AttName>
			<Institution>The University of Texas Health Science Center at Houston, Houston, TX, USA</Institution>
		</Header>
		<Header title="Cedars Sinai Investigators">
			<AttName>Jerome Rotter, MD</AttName>
			<Institution>Cedars Sinai, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Cedars Sinai Investigators">
			<AttName>Xiuqing Guo, PhD</AttName>
			<Institution>Cedars Sinai, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Cedars Sinai Investigators">
			<AttName>Vii-Der Ida Chen, PhD</AttName>
			<Institution>Cedars Sinai, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="U. of Washington Investigators">
			<AttName>Richard Kronmal, PhD</AttName>
			<Institution>University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="U. of Washington Investigators">
			<AttName>Craig Johnson</AttName>
			<Institution>University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="NIH Officials">
			<AttName>Dina Paltoo, PhD</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="NIH Officials">
			<AttName>George Papanicolaou, PhD</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="NIH Officials">
			<AttName>Deborah Applebaum-Bowden, PhD</AttName>
			<Institution>National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U01 HL080443</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="SEA" url="http://www.sea-nhlbi.org/default.aspx"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p> 		<ol> 			<li>2005 - Grant funded</li> 			<li>2006 - DNA extraction and preparation</li> 			<li>2007 - Phase I genotyping completed</li> 			<li>2008 - Phase II genotyping completed</li> 			<li>2009 - Phase III genotyping completed</li> 			<li>2010 - Phase III analyses completed</li> 		</ol> 	</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>nhlbigeneticdata@nhlbi.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacFax>(301) 480-1455</DacFax>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000349.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000349.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000349.v1.p1" FileName="SEA_Study_DbGap_DUCrev-1.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>This dataset has no restrictions on use.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd003526.1" type="protocol" createDate="2011-03-29" modDate="2011-04-07" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd003526.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000349.v1.p1&amp;phd=3526">
      <OrigName>SEA_Phase2_Methods_03022011.doc</OrigName>
      <DisplayName>SEA Phase 2 Methods</DisplayName>
      <Description>SEA Phase 2 Methods</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
